Evidence map›Paper›PMID 40269150›Full record

ArticleScientific reports2025

Development of manganese ferrite coated with Prussian blue as an efficient contrast agent for applications in magnetic resonance imaging.

Ágnes Maria Ilosvai, Fatemeh Heydari, László Forgách, Noémi Kovács, Krisztián Szigeti, Domokos Máthé, Ferenc Kristály, Lajos Daróczi, Béla Viskolcz, Miklós Nagy and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Engineering copper ferrite (CuFeMicrosystems & nanoengineering · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ágnes Maria IlosvaiInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, Miskolc, 3515, Hungary.
Fatemeh HeydariDepartment of Biophysics and Radiation Biology, Semmelweis University, Budapest, 1094, Hungary.
László ForgáchDepartment of Biophysics and Radiation Biology, Semmelweis University, Budapest, 1094, Hungary. forgach.laszlo@med.semmelweis-univ.hu.
Noémi KovácsDepartment of Biophysics and Radiation Biology, Semmelweis University, Budapest, 1094, Hungary.
Krisztián SzigetiDepartment of Biophysics and Radiation Biology, Semmelweis University, Budapest, 1094, Hungary.
Domokos MáthéDepartment of Biophysics and Radiation Biology, Semmelweis University, Budapest, 1094, Hungary.
Ferenc KristályInstitute of Mineralogy and Geology, University of Miskolc, Miskolc, 3515, Hungary.
Lajos DarócziDepartment of Solid State Physics, University of Debrecen, P.O. Box 2, Debrecen, 4010, Hungary.
Béla ViskolczInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, Miskolc, 3515, Hungary.
Miklós NagyInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, Miskolc, 3515, Hungary.
Miklós NémethSurface Chemistry and Catalysis Department, Institute for Energy Security and Environmental Safety, HUN-REN Centre for Energy Research, Budapest, 1121, Hungary.
Tamás OllárSurface Chemistry and Catalysis Department, Institute for Energy Security and Environmental Safety, HUN-REN Centre for Energy Research, Budapest, 1121, Hungary.
László VanyorekInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, Miskolc, 3515, Hungary. laszlo.vanyorek@uni-miskolc.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic iron oxide nanoparticles are frequently utilized as contrast agents in magnetic resonance imaging (MRI). However, the release of iron ions leads to the formation of reactive oxygen species (ROS), resulting in cell damage. In this study, we developed MRI contrast agents containing amine-functionalized MnFe

Indexed as

Contrast MediaFerric CompoundsFerrocyanidesMagnetic Resonance ImagingManganese CompoundsPrussian Blue ReactionAnimalsHEK293 CellsHumansParticle SizeContrast MediaFerric Compoundsferric ferrocyanideFerrocyanidesManganese Compoundsmanganese ferriteFerriteMagnetic nanoparticlesMRINon-toxicPrussian blue

Identifiers

PMID40269150
PMCPMC12019548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.